News
Novo Nordisk, the Danish pharmaceutical giant behind obesity drug, Wegovy, has engaged Slingshot to develop and manage its ...
Slingshot has won Novo Nordisk and the Dry July Foundation as clients.The announcement:Independent creative media agency, ...
Independent creative media agency, Slingshot, has been appointed by two health-focused clients to manage media following competitive pitches. Novo Nordisk, the Danish pharmaceutical giant behind ...
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ ...
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
U.S. pharma giant Eli Lilly And Co (NYSE:LLY) announced the launch of its popular weight loss drug Mounjaro (tirzepatide) in ...
Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk , nearly doubled annual income and investment returns to a record 8 billion euros ($8.66 billion) in 2024, it said on ...
The Novo Nordisk Foundation’s project to explore food processing has created some controversy of late. Initially, the project was framed as ‘the next generation’ of the ‘Nova’ classification, with its ...
The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...
The partnership, which builds on WFP's long-standing work to address school hunger globally, will run from January 2025 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results